-+ 0.00%
-+ 0.00%
-+ 0.00%

ADITXT SUBSIDIARY ADIMUNE ANNOUNCES POSITIVE RESULTS FROM MAYO CLINIC PRE-CLINICAL STUDIES TO SUPPORT FDA AND EUROPEAN REGULATORY SUBMISSIONS FOR TYPE 1 DIABETES, PSORIASIS, AND STIFF PERSON SYNDROME HUMAN TRIALS

Reuters·04/14/2025 12:15:00

Please log in to view news